Thomas A Pearson,
CO PROF
Department:
Department of Epidemiology
Business Phone:
(352) 273-5048
Business Email:
tapearson@ufl.edu
About Thomas A Pearson
Dr. Pearson is a Professor of Epidemiology and Medicine at the University of Florida Health Sciences Center and currently serves as the Director of UF’s MD-PhD Program and. He also is Director of the Translational Workforce Development of the UF Clinical and Translational Science Award Program and Principal Investigator of its Mentored Career Development Award Program(KL2). Dr. Pearson also directs the MD-PhD Program in the UF College of Medicine and serves as one of multiple Principal Investigators for an Institutional Training Grant (T32) in Genomic Medicine, centered in the UF College of Pharmacy.
Dr. Pearson received his Doctor of Medicine, Master in Public Health, and Doctor of Philosophy in cardiovascular epidemiology, all from the Johns Hopkins University, where he also completed residencies in preventive medicine and internal medicine and a fellowship in cardiology. He holds board certifications in Internal Medicine, Preventive Medicine, and Clinical Lipidology. Dr. Pearson is a Fellow of the American Heart Association, the American College of Preventive Medicine, and the American College of Physicians. Dr. Pearson has served as a member and chair of important committees of the National Heart, Lung, and Blood Institute, the Institute of Medicine, the American Heart Association, and the American College of Cardiology. He has lectured and published extensively in the prevention of cardiovascular disease at the patient, healthcare system, community, and public policy levels.
Accomplishments
Epidemiology and Prevention Mentoring Award,
2019
·
American Heart Association Council on Epidemiology and Prevention
Distinguished Lecture in Cardiovascular Medicine
2017
·
University of Alabama – Birmingham
National Forum Leadership Award
2014
·
National Forum for Heart Disease and Stroke Prevention
Joseph Stokes III Memorial Lecturer
2013
·
Boston University School of Medicine
Heart Healthy and Stroke Free Award
2012
·
National Forum for Prevention of Heart Disease and Stroke
National Forum Service Award
2012
·
National Forum for Heart Disease and Stroke Prevention
Lyon Founder's Award
2011
·
Rochester School for the Deaf
Special Lifetime Mentoring Award
2010
·
University of Rochester School of Medicine and Dentistry
Johns Hopkins Society of Scholars
2009
·
Johns Hopkins University
Medicine Hedersdoktor
2002
·
University of Umea
Fellow
1992
·
American College of Cardiology
Fellow
1987
·
American College of Preventive Medicine
Fellow, American College of Physicisans
1987
·
American College of Physicians
Delta Omega
1983
·
Johns Hopkins University School of Hygiene and Public Health
Alpha Omega Alpha
1976
·
Johns Hopkins University School of Medicine
Phi Beta Kappa
1971
·
University of Wisconsin-Madison
Teaching Profile
Courses Taught
2018-2020
PHC6598 Foundations in Precision Medicine: Genetic Epidemiology
2020-2021
PHC7918 Independent Study
2019-2021
PHC6003 Epidemiology of Chronic Diseases and Disability
2020,2023-2024
GMS6847 Translational Research and Therapeutics: Bench, Bedside, Community, & Policy
2020
PHC6946 Public Health Internship
2020
PHC6601 Seminar in Contemporary Public Health Issues
2018
GMS7980 Research for Doctoral Dissertation
2018
PHC6008 Cardiovascular Epidemiology
2018
HLP7979 Advanced Research in Health and Human Performance
2018
BMS6812 Intro Clin Med 2
2017
PHC4101 Public Health Concepts
2015
GMS7093 Introduction to Clinical and Translational Research
2021-2022
PHC7979 Advanced Research
2022
PHC6941 MPH Applied Practice Experience
2022-2024
PHC7980 Research for Doctoral Dissertation
Board Certifications
-
Clinical LipidologyAmerican Board of Clinical Lipidology
-
Internal MedicineAmerican Board of Internal Medicine
-
Preventive Medicine and Public HealthAmerican Board of Preventive Medicine
Research Profile
Thomas A. Pearson, MD, MPH, PhD, is Professor of Epidemiology and Medicine at the University of Florida Health Science Center. Dr. Pearson received his Doctor of Medicine, Master in Public Health, and Doctor of Philosophy in cardiovascular epidemiology, all from the Johns Hopkins University, where he also completed residencies in preventive medicine and internal medicine and a fellowship in cardiology. He holds board certifications in Internal Medicine, Preventive Medicine, and Clinical Lipidology. Dr. Pearson is a Fellow of the American Heart Association, American College of Cardiology, the American College of Preventive Medicine, the American College of Physicians, and the National Lipid Association. Dr. Pearson’s major research interests are in the epidemiology and prevention of atherosclerotic cardiovascular disease, with a special interest in the prevention and treatment of disorders of lipids and lipoproteins. He has actively participated in basic science studies, clinical investigations, and community-based projects. He has previously been Principal Investigator/Program Director for numerous NIH research and training grants, a CDC Prevention Center, and a Clinical and Translational Science Award. He currently directs the Translational Workforce Development Program, the KL2 Program and the Precision Public Health Working Group of the UF Clinical andTranslational Science Institute.
Open Researcher and Contributor ID (ORCID)
0000-0001-8370-0595
Publications
2024
Donor Electrocardiogram Associations With Cardiac Dysfunction, Heart Transplant Use, and Survival: The Donor Heart Study.
JACC. Heart failure.
12(4):722-736
[DOI] 10.1016/j.jchf.2023.12.007.
[PMID] 38244008.
2024
The Science of Precision Prevention: Research Opportunities and Clinical Applications to Reduce Cardiovascular Health Disparities.
JACC. Advances.
3(1)
[DOI] 10.1016/j.jacadv.2023.100759.
[PMID] 38375059.
2023
An international perspective on low-dose aspirin for the primary prevention of myocardial infarction.
International journal of cardiology.
373:17-22
[DOI] 10.1016/j.ijcard.2022.11.036.
[PMID] 36442672.
2023
Deaf Weight Wise: A novel randomized clinical trial with Deaf sign language users.
Obesity (Silver Spring, Md.).
31(4):965-976
[DOI] 10.1002/oby.23702.
[PMID] 36890106.
2023
Developing and validating a natural language processing algorithm to extract preoperative cannabis use status documentation from unstructured narrative clinical notes.
Journal of the American Medical Informatics Association : JAMIA.
30(8):1418-1428
[DOI] 10.1093/jamia/ocad080.
[PMID] 37178155.
2023
Impact of COVID-19 on the Research Career Advancement of Health Equity Scholars from Diverse Backgrounds.
International journal of environmental research and public health.
20(6)
[DOI] 10.3390/ijerph20064750.
[PMID] 36981658.
2023
Individual and Institutional Factors Contribute to Research Capacity Building for Early-Stage Investigators from Groups Underrepresented in Biomedical Research: A Qualitative Comparative Analysis.
International journal of environmental research and public health.
20(9)
[DOI] 10.3390/ijerph20095662.
[PMID] 37174180.
2023
Left Ventricular Dysfunction Associated With Brain Death: Results From the Donor Heart Study.
Circulation.
148(10):822-833
[DOI] 10.1161/CIRCULATIONAHA.122.063400.
[PMID] 37465972.
2023
The Role of Mock Reviewing Sessions in the National Research Mentoring Network Strategic Empowerment Tailored for Health Equity Investigators: A Randomized Controlled Study.
International journal of environmental research and public health.
20(9)
[DOI] 10.3390/ijerph20095738.
[PMID] 37174259.
2022
Challenges encountered in conducting donor-based research: Lessons learned from the Donor Heart Study.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
22(7):1760-1765
[DOI] 10.1111/ajt.17051.
[PMID] 35373509.
2022
Emergency department condition acuity, length of stay, and revisits among deaf and hard-of-hearing patients: A retrospective chart review.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
29(11):1290-1300
[DOI] 10.1111/acem.14573.
[PMID] 35904003.
2022
Emergency department utilization among deaf and hard-of-hearing patients: A retrospective chart review.
Disability and health journal.
15(3)
[DOI] 10.1016/j.dhjo.2022.101327.
[PMID] 35581134.
2022
Risk Factors Associated With New-Onset Myocardial Perfusion Abnormalities in Kidney Transplant Candidates.
The American journal of cardiology.
174:84-88
[DOI] 10.1016/j.amjcard.2022.03.030.
[PMID] 35504743.
2021
Aspirin in Primary Prevention: What Changed? A Critical Appraisal of Current Evidence.
The American journal of cardiology.
141:38-48
[DOI] 10.1016/j.amjcard.2020.11.014.
[PMID] 33221264.
2021
Conceptual Model of Emergency Department Utilization among Deaf and Hard-of-Hearing Patients: A Critical Review.
International journal of environmental research and public health.
18(24)
[DOI] 10.3390/ijerph182412901.
[PMID] 34948509.
2021
Randomized Controlled Study to Test the Effectiveness of Developmental Network Coaching in the Career Advancement of Diverse Early-Stage Investigators (ESIs): Implementation Challenges and Lessons Learned.
International journal of environmental research and public health.
18(22)
[DOI] 10.3390/ijerph182212003.
[PMID] 34831759.
2021
Somatic Mutations in “Benign” Disease.
The New England journal of medicine.
385(11)
[DOI] 10.1056/NEJMc2110545.
[PMID] 34496189.
2020
An external exposome-wide association study of hypertensive disorders of pregnancy.
Environment international.
141
[DOI] 10.1016/j.envint.2020.105797.
[PMID] 32413622.
2020
Design and methodology challenges of environment-wide association studies: A systematic review.
Environmental research.
183
[DOI] 10.1016/j.envres.2020.109275.
[PMID] 32105887.
2020
Precision Health Analytics With Predictive Analytics and Implementation Research: JACC State-of-the-Art Review.
Journal of the American College of Cardiology.
76(3):306-320
[DOI] 10.1016/j.jacc.2020.05.043.
[PMID] 32674794.
2020
The Type and Amount of Dietary Fat Affect Plasma Factor VIIc, Fibrinogen, and PAI-1 in Healthy Individuals and Individuals at High Cardiovascular Disease Risk: 2 Randomized Controlled Trials.
The Journal of nutrition.
150(8):2089-2100
[DOI] 10.1093/jn/nxaa137.
[PMID] 32492148.
2019
Assessment of Mortality and Smoking Rates Before and After Reduction in Community-wide Prevention Programs in Rural Maine.
JAMA network open.
2(6)
[DOI] 10.1001/jamanetworkopen.2019.5877.
[PMID] 31199453.
2018
Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores.
Journal of the American Heart Association.
7(16)
[DOI] 10.1161/JAHA.118.009754.
[PMID] 30369320.
2018
Assessing the added predictive ability of a metabolic syndrome severity score in predicting incident cardiovascular disease and type 2 diabetes: the Atherosclerosis Risk in Communities Study and Jackson Heart Study.
Diabetology & metabolic syndrome.
10
[DOI] 10.1186/s13098-018-0344-3.
[PMID] 29796112.
2018
Risk of Coronary Events 55 Years after Thymic Irradiation in the Hempelmann Cohort.
Cardio-oncology (London, England).
4
[DOI] 10.1186/s40959-018-0027-0.
[PMID] 30381795.
2018
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Lancet (London, England).
392(10152):1036-1046
[DOI] 10.1016/S0140-6736(18)31924-X.
[PMID] 30158069.
2017
ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Circulation.
135(9):e122-e137
[DOI] 10.1161/CIR.0000000000000481.
[PMID] 28126839.
2017
ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Journal of the American College of Cardiology.
69(8):1076-1092
[DOI] 10.1016/j.jacc.2016.11.004.
[PMID] 28132746.
2017
Assessing the Added Predictive Ability of a Metabolic Syndrome Severity Score in Predicting Incident Cardiovascular Disease and Type 2 Diabetes: The Atherosclerosis Risk in Communities Study & Jackson Heart Study
Diabetes and Vascular Disease Research.
2017
Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group
Circulation.
135:e122-e137
2017
Collaboration With Deaf Communities to Conduct Accessible Health Surveillance.
American journal of preventive medicine.
52(3 Suppl 3):S250-S254
[DOI] 10.1016/j.amepre.2016.10.011.
[PMID] 28215374.
2017
Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study.
Diabetologia.
60(7):1261-1270
[DOI] 10.1007/s00125-017-4267-6.
[PMID] 28378033.
2017
Independent Associations Between Metabolic Syndrome Severity and Future Coronary Heart Disease by Sex and Race.
Journal of the American College of Cardiology.
69(9):1204-1205
[DOI] 10.1016/j.jacc.2016.10.088.
[PMID] 28254184.
2017
Understanding the Impact of Hyperlipidemia Treatment on Medical Expenditures for Cardiovascular Disease.
Medical care.
55(1):1-3
[PMID] 27930502.
2015
Assessing Health Literacy in Deaf American Sign Language Users.
Journal of health communication.
20 Suppl 2(0 2):92-100
[DOI] 10.1080/10810730.2015.1066468.
[PMID] 26513036.
2015
Community-wide cardiovascular disease prevention programs and health outcomes in a rural county, 1970-2010.
JAMA.
313(2):147-55
[DOI] 10.1001/jama.2014.16969.
[PMID] 25585326.
2015
JCL Roundtable: Gender differences in reduction of CVD in response to lipid-lowering drugs.
Journal of clinical lipidology.
9(5):624-33
[DOI] 10.1016/j.jacl.2015.07.010.
[PMID] 26350807.
2014
Higher educational attainment but not higher income is protective for cardiovascular risk in Deaf American Sign Language (ASL) users.
Disability and health journal.
7(1):49-55
[DOI] 10.1016/j.dhjo.2013.07.001.
[PMID] 24411507.
2014
Identifying emerging research collaborations and networks: method development.
Evaluation & the health professions.
37(1):19-32
[DOI] 10.1177/0163278713501693.
[PMID] 24019209.
2014
Monthly haemostatic factor variability in women and men.
European journal of clinical investigation.
44(3):309-18
[DOI] 10.1111/eci.12235.
[PMID] 24382103.
2013
American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers.
Circulation.
127(16):1730-53
[DOI] 10.1161/CIR.0b013e31828f8a94.
[PMID] 23519758.
2013
Commentary: What are the benefits of training deaf and hard-of-hearing doctors?
Academic medicine : journal of the Association of American Medical Colleges.
88(2):158-61
[DOI] 10.1097/ACM.0b013e31827c0aef.
[PMID] 23361028.
2012
An epidemiologic transition of cardiovascular disease risk in Carriacou and Petite Martinique, Grenada: the Grenada Heart Project, 2005-2007.
Preventing chronic disease.
9
[PMID] 22515972.
2012
Are central institutional review boards the solution? The National Heart, Lung, and Blood Institute Working Group’s report on optimizing the IRB process.
Academic medicine : journal of the Association of American Medical Colleges.
87(12):1710-4
[DOI] 10.1097/ACM.0b013e3182720859.
[PMID] 23095928.
2012
Carotid endarterectomy and carotid artery stenting utilization trends over time.
BMC neurology.
12
[DOI] 10.1186/1471-2377-12-17.
[PMID] 22458607.
2012
Engaging the Deaf American sign language community: lessons from a community-based participatory research center.
Progress in community health partnerships : research, education, and action.
6(3):321-9
[DOI] 10.1353/cpr.2012.0037.
[PMID] 22982845.
2012
Policy Depot: A Tool to Build Global Capacity in Cardiovascular Health Policy.
Global Heart.
7(1)
2012
Preparedness of the CTSA’s structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS).
Clinical and translational science.
5(2):121-9
[DOI] 10.1111/j.1752-8062.2012.00401.x.
[PMID] 22507116.
2012
Preparedness of the CTSA’s Structural and Scientific Assets to Support the Mission of the National Center for Advancing Translational Sciences (NCATS).
.
5(2):121-129
2012
Search for a light pseudoscalar Higgs boson in the dimuon decay channel in pp collisions at √s = 7 TeV.
Physical review letters.
109(12)
[PMID] 23005937.
2012
Search for a W’ or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV.
Physical review letters.
109(14)
[PMID] 23083236.
2012
Search for dark matter and large extra dimensions in pp collisions yielding a photon and missing transverse energy.
Physical review letters.
108(26)
[PMID] 23004964.
2012
Search for heavy neutrinos and W(R) bosons with right-handed couplings in a left-right symmetric model in pp collisions at sqrt[s]=7 TeV.
Physical review letters.
109(26)
[PMID] 23368549.
2012
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV.
Physical review letters.
109(17)
[PMID] 23215177.
2012
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy.
Physical review letters.
109(7)
[PMID] 23006358.
2012
Search for signatures of extra dimensions in the diphoton mass spectrum at the large hadron collider.
Physical review letters.
108(11)
[PMID] 22540461.
2012
Search for the standard model Higgs boson in the decay channel H→ZZ→4ℓ in pp collisions at √s=7 TeV.
Physical review letters.
108(11)
[PMID] 22540464.
2012
Study of the Dijet mass spectrum in pp → W+jets events at sqrt[s] = 7 TeV.
Physical review letters.
109(25)
[PMID] 23368450.
2011
Age as a modulator of inflammatory cardiovascular risk factors.
Arteriosclerosis, thrombosis, and vascular biology.
31(9):2151-6
[DOI] 10.1161/ATVBAHA.111.232348.
[PMID] 21700927.
2011
AHA/ASA Guidelines for the Primary Prevention of Stroke. A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association Council on Stroke
.
42(2):517-584
2011
Community participatory research with deaf sign language users to identify health inequities.
American journal of public health.
101(12):2235-8
[DOI] 10.2105/AJPH.2011.300247.
[PMID] 22021296.
2011
CTSA-IP: A Solution to Identifying and Aggregating Intellectual Property across the NIH Clinical-Translational Science Award (CTSA) Consortium of Biomedical Research Institutes
.
4(5):328-331
2011
CTSA-IP: a solution to identifying and aggregating intellectual property across the NIH Clinical Translational Science Award (CTSA) consortium of biomedical research institutes.
Clinical and translational science.
4(5):328-31
[DOI] 10.1111/j.1752-8062.2011.00308.x.
[PMID] 22029803.
2011
Deaf sign language users, health inequities, and public health: opportunity for social justice.
Preventing chronic disease.
8(2)
[PMID] 21324259.
2011
Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians.
Translational research : the journal of laboratory and clinical medicine.
158(2):92-8
[DOI] 10.1016/j.trsl.2011.01.004.
[PMID] 21757153.
2011
Dijet azimuthal decorrelations in pp collisions at √s=7 TeV.
Physical review letters.
106(12)
[PMID] 21517306.
2011
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
Stroke.
42(2):517-84
[DOI] 10.1161/STR.0b013e3181fcb238.
[PMID] 21127304.
2011
Identification of those at risk for diabetes mellitus can comparative effectiveness research provide the answer?
American journal of preventive medicine.
40(1):101-3
[DOI] 10.1016/j.amepre.2010.10.011.
[PMID] 21146774.
2011
Impact of communication on preventive services among deaf American Sign Language users.
American journal of preventive medicine.
41(1):75-9
[DOI] 10.1016/j.amepre.2011.03.004.
[PMID] 21665066.
2011
Indications of suppression of excited Υ states in Pb-Pb collisions at √(s(NN))=2.76 TeV.
Physical review letters.
107(5)
[PMID] 21867063.
2011
Knowledge, perception, and behaviors of relatives of people with premature heart disease: a systematic literature review.
Circulation.
124(8):958-64
[DOI] 10.1161/CIRCULATIONAHA.110.940593.
[PMID] 21859983.
2011
Measurement of dijet angular distributions and search for quark compositeness in pp collisions at √s = 7 TeV.
Physical review letters.
106(20)
[PMID] 21668222.
2011
Measurement of the B(+) production cross section in pp collisions at sqrt[s]=7 TeV.
Physical review letters.
106(11)
[PMID] 21469857.
2011
Measurement of the B0 production cross section in pp collisions at sqrt[s] = 7 TeV.
Physical review letters.
106(25)
[PMID] 21770632.
2011
Measurement of the isolated prompt photon production cross section in pp collisions at √s=7 TeV.
Physical review letters.
106(8)
[PMID] 21405566.
2011
Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC.
Physical review letters.
107(2)
[PMID] 21797595.
2011
Measurement of the t-channel single top quark production cross section in pp collisions at √s=7 TeV.
Physical review letters.
107(9)
[PMID] 21929225.
2011
Public policy approaches to the prevention of heart disease and stroke.
Circulation.
124(23):2560-71
[DOI] 10.1161/CIRCULATIONAHA.110.968743.
[PMID] 22144633.
2011
Search for a vectorlike quark with charge 2/3 in t+Z events from pp collisions at √s=7 TeV.
Physical review letters.
107(27)
[PMID] 22243304.
2011
Search for B(s)(0) → μ+ μ- and B(0) → μ+ μ- decays in pp collisions at sqrt[s] = 7 TeV.
Physical review letters.
107(19)
[PMID] 22181597.
2011
Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV.
Physical review letters.
106(23)
[PMID] 21770497.
2011
Search for pair production of first-generation scalar leptoquarks in pp collisions at √s = 7 TeV.
Physical review letters.
106(20)
[PMID] 21668220.
2011
Search for pair production of second-generation scalar leptoquarks in pp collisions at √s = 7 TeV.
Physical review letters.
106(20)
[PMID] 21668221.
2011
Search for stopped Gluinos in pp collisions at square root s=7 TeV.
Physical review letters.
106(1)
[PMID] 21231732.
2011
Search for supersymmetry in pp collisions at √7 TeV in events with two photons and missing transverse energy.
Physical review letters.
106(21)
[PMID] 21699288.
2011
Search for three-jet resonances in pp collisions at square root(s)=7 TeV.
Physical review letters.
107(10)
[PMID] 21981492.
2011
Study of Z Boson Production in PbPb Collisions at √S(NN)=2.76 TeV.
Physical review letters.
106(21)
[PMID] 21699291.
2011
The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association.
Circulation.
123(10):1138-43
[DOI] 10.1161/CIR.0b013e31820d0793.
[PMID] 21233236.
2011
The quality of lifestyle and the quality of life.
Archives of internal medicine.
171(20):1819-20
[DOI] 10.1001/archinternmed.2011.442.
[PMID] 21911620.
2010
AJC editor’s consensus: rheumatoid arthritis and atherosclerotic cardiovascular disease.
The American journal of cardiology.
106(3):442-7
[DOI] 10.1016/j.amjcard.2010.04.005.
[PMID] 20643261.
2010
Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians.
The Journal of clinical endocrinology and metabolism.
95(5):2376-83
[DOI] 10.1210/jc.2009-2498.
[PMID] 20194707.
2010
Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.
Atherosclerosis.
211(2):526-30
[DOI] 10.1016/j.atherosclerosis.2010.03.021.
[PMID] 20444451.
2010
Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
19(1):48-58
[DOI] 10.1158/1055-9965.EPI-09-0520.
[PMID] 20056622.
2010
Building Capacity Across the Spectrum of Research Translation: Centers of Excellence Within the Rochester Clinical and Translational Science Institute
Cts-Clinical and Translational Science.
3(6):272-274
[DOI] 10.1111/j.1752-8062.2010.00234.x.
[PMID] 21207875.
2010
Building capacity across the spectrum of research translation: centers of excellence within the Rochester Clinical and Translational Science Institute.
Clinical and translational science.
3(6):272-4
[PMID] 21207875.
2010
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.
Lancet (London, England).
376(9740):517-23
[DOI] 10.1016/S0140-6736(10)60935-X.
[PMID] 20709233.
2010
Search for dijet resonances in 7 TeV pp collisions at CMS.
Physical review letters.
105(21)
[PMID] 21231289.
2010
Search for quark compositeness with the dijet centrality ratio in pp collisions at √s=7 TeV.
Physical review letters.
105(26)
[PMID] 21231646.
2010
Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the Hempelmann cohort.
Radiation research.
174(6):753-62
[DOI] 10.1667/RR2181.1.
[PMID] 21128799.
2010
Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans.
The American journal of cardiology.
106(9):1264-9
[DOI] 10.1016/j.amjcard.2010.06.056.
[PMID] 21029822.
2009
2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women’s Health Research
Journal of the American College of Cardiology.
54(14):1364-1405
2009
ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women’s Health Research.
Journal of the American College of Cardiology.
54(14):1364-405
[DOI] 10.1016/j.jacc.2009.08.005.
[PMID] 19778679.
2009
AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women’s Health Research.
Circulation.
120(13):1296-336
[DOI] 10.1161/CIRCULATIONAHA.109.192617.
[PMID] 19770388.
2009
ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans.
Journal of lipid research.
50(7):1472-8
[DOI] 10.1194/jlr.P900012-JLR200.
[PMID] 19252179.
2009
Comparison of C-Reactive Protein and Metabolic Syndrome As Cardiovascular Risk Factors in African-Americans and European-Americans
American Journal of Cardiology.
103(4):523-527
[DOI] 10.1016/j.amjcard.2009.10.016.
2009
Comparison of C-reactive protein and metabolic syndrome as cardiovascular risk factors in African-Americans and European-Americans.
The American journal of cardiology.
103(4):523-7
[DOI] 10.1016/j.amjcard.2008.10.016.
[PMID] 19195514.
2009
Effect of Irbesartan and Enalapril in Non-ST Elevation Acute Coronary Syndrome: Results of the Randomized Double-Blind ARCHIPELAGO Study
.
30(22):2733-2741
2009
Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study.
European heart journal.
30(22):2733-41
[DOI] 10.1093/eurheartj/ehp301.
[PMID] 19700470.
2009
Fewer deaths from cardiovascular disease than expected from the Systematic Coronary Risk Evaluation chart in a Swedish population.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
16(3):321-4
[DOI] 10.1097/HJR.0b013e328322c760.
[PMID] 19357519.
2009
Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
The American journal of cardiology.
103(3):369-74
[DOI] 10.1016/j.amjcard.2008.09.090.
[PMID] 19166691.
2009
Repeat attenders at National Health Service walk-in centres – a descriptive study using routine data.
Public health.
123(7):506-10
[DOI] 10.1016/j.puhe.2009.06.008.
[PMID] 19604528.
2009
Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians.
Atherosclerosis.
205(1):290-5
[DOI] 10.1016/j.atherosclerosis.2008.11.028.
[PMID] 19135196.
2009
Translation of evidence-based guidelines in preventive cardiology: the EUROACTION program.
Nature clinical practice. Cardiovascular medicine.
6(1):8-9
[DOI] 10.1038/ncpcardio1386.
[PMID] 18941437.
2008
A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing committee to Develop Clinical Performance Measures for Primary Prevention of Cardiovascular Disease)
.
2008
Building capacity for heart disease and stroke prevention research: the cardiovascular health intervention research and translation network
.
9(3):220-227
2008
Building capacity for heart disease and stroke prevention research: the cardiovascular health intervention research and translation network.
Health promotion practice.
9(3):220-7
[DOI] 10.1177/1524839908319168.
[PMID] 18560014.
2008
Cardiovascular Health in the Developing World: Community Perceptions from Carriacou, Grenada
.
3(3):123-131
2008
Cardiovascular Health in the Developing World: Community Perceptions from Carriacou, Grenada.
CVD prevention and control.
3(3):123-131
[PMID] 19730702.
2008
Elevated blood pressure, race/ethnicity, and C-reactive protein levels in children and adolescents.
Pediatrics.
122(6):1252-7
[DOI] 10.1542/peds.2007-3162.
[PMID] 19047242.
2008
Heightened risk of cardiovascular disease in patients with rheumatoid arthritis, heightened risk of cardiovascular disease in patients with rheumatoid arthritis. Introduction.
The American journal of medicine.
121(10 Suppl 1):S1-2
[DOI] 10.1016/j.amjmed.2008.06.009.
[PMID] 18926164.
2008
High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans.
The Journal of clinical endocrinology and metabolism.
93(4):1482-8
[DOI] 10.1210/jc.2007-2416.
[PMID] 18252779.
2008
How to interpret a genome-wide association study.
JAMA.
299(11):1335-44
[DOI] 10.1001/jama.299.11.1335.
[PMID] 18349094.
2008
The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians.
Atherosclerosis.
201(1):138-47
[DOI] 10.1016/j.atherosclerosis.2008.01.002.
[PMID] 18304554.
2008
Training medical students in community health: a novel required fourth-year clerkship at the University of Rochester.
Academic medicine : journal of the Association of American Medical Colleges.
83(4):357-64
[DOI] 10.1097/ACM.0b013e3181668410.
[PMID] 18367896.
2008
Where do we go from here?
The American journal of medicine.
121(10 Suppl 1):S32-4
[DOI] 10.1016/j.amjmed.2008.06.013.
[PMID] 18926168.
2007
Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity.
Translational research : the journal of laboratory and clinical medicine.
149(6):317-23
[PMID] 17543850.
2007
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
European heart journal.
28(18):2200-7
[PMID] 17673448.
2007
ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study.
Journal of lipid research.
48(3):693-8
[PMID] 17172560.
2007
Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
The American journal of cardiology.
99(12):1706-1713
[PMID] 17560879.
2007
Comparison of Monounsaturated Fat with Carbohydrates as a Replacement for Saturated Fat in Subjects with a High Metabolic Risk Profile: Studies in the Fasting and Postprandial States
.
86(6):1611-1620
2007
Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states.
The American journal of clinical nutrition.
86(6):1611-20
[PMID] 18065577.
2007
Gender Disparities in the Diagnosis, Treatment, and Prevention of Coronary Heart Disease – Are Men and Women Treated Equally?
.
2(2)
2007
In the Clinic. Dislipidemia
.
2007
In the clinic. Dyslipidemia.
Annals of internal medicine.
147(5):ITC9-1
[PMID] 17785482.
2007
Incidence of coronary artery disease in siblings of patients with premature coronary artery disease: 10 years of follow-up.
The American journal of cardiology.
100(9):1410-5
[PMID] 17950799.
2007
Metabolic syndrome components in african-americans and European-american patients and its relation to coronary artery disease.
The American journal of cardiology.
100(5):830-4
[PMID] 17719328.
2007
Organizing services for cardiovascular prevention.
Current treatment options in cardiovascular medicine.
9(4):278-86
[PMID] 17761113.
2007
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
Journal of the American College of Cardiology.
49(19):1982-8
[PMID] 17498584.
2007
Racial variations in the choice of on-pump versus off-pump CABG surgery.
.
12(1):31-35
2007
Racial variations in the choice of on-pump versus off-pump coronary artery bypass grafting.
Journal of health services research & policy.
12(1):31-5
[PMID] 17244395.
2007
Surgeons Learning New Techniques and Patients’ Race: Evidence from CABG surgery in New York State
.
2007
The prevention of cardiovascular disease: have we really made progress?
Health affairs (Project Hope).
26(1):49-60
[PMID] 17211013.
2007
Who is maintaining weight in a middle-aged population in Sweden? A longitudinal analysis over 10 years.
BMC public health.
7
[PMID] 17565692.
2006
A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
6(5 Pt 1):876-83
[PMID] 16611323.
2006
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
Journal of the American College of Cardiology.
47(10):2130-9
[PMID] 16697342.
2006
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
Circulation.
113(19):2363-72
[PMID] 16702489.
2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
Journal of internal medicine.
259(3):247-58
[PMID] 16476102.
2006
Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a].
Journal of lipid research.
47(5):982-9
[PMID] 16495513.
2006
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
The New England journal of medicine.
354(16):1706-17
[PMID] 16531616.
2006
Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: a Substudy of the Ezetimibe Add-on to Statin for Effectiveness Trial
.
81(9):1177-1185
2006
Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness trial.
Mayo Clinic proceedings.
81(9):1177-85
[PMID] 16970214.
2006
Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II.
Journal of general internal medicine.
21(4):320-6
[PMID] 16686806.
2006
Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome.
Diabetes & vascular disease research.
3(2):93-102
[PMID] 17058629.
2006
High obesity incidence in northern Sweden: how will Sweden look by 2009?
European journal of epidemiology.
21(5):377-82
[PMID] 16763883.
2006
Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol.
Journal of lipid research.
47(11):2475-81
[PMID] 16888319.
2006
Shifting Body Mass Distributions in Predominantly Rural Communities: A Comparison of Northern Sweden and Upstate New York
.
2006
The Cardiovascular Implications of Omega-3 Fatty Acids
.
13(7):557-569
2006
Transplanting the highly sensitized patient: The emory algorithm.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
6(10):2307-15
[PMID] 16939516.
2005
A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Added to Statin Effectiveness (EASE) Study
.
80:587-595
2005
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
Mayo Clinic proceedings.
80(5):587-95
[PMID] 15887425.
2005
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
American heart journal.
150(3)
[PMID] 16169314.
2005
Aronow’s “Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?” Commentary.
The journals of gerontology. Series A, Biological sciences and medical sciences.
60(5):597-8; author reply 602
[PMID] 16094772.
2005
Combination niacin and statin therapy in primary and secondary prevention of cardiovascular disease.
Clinical cardiology.
28(7):317-20
[PMID] 16075823.
2005
Commentary: Aronow’s “Should the NCEP III Guidelines be Changed in Elderly and Younger Persons at High Risk for Cardiovascular Events?” What Do We Do for the Very Old?”
.
60A(5):593-602
2005
Comprehensive Endovascular Therapy for Femoropopliteal Arterial Atherosclerotic Occlusive Disease
.
201(2):275-296
2005
Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease.
Journal of the American College of Surgeons.
201(2):275-96
[PMID] 16038827.
2005
Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
The American journal of geriatric pharmacotherapy.
3(4):218-28
[PMID] 16503317.
2005
Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease.
The American journal of cardiology.
95(7):862-4
[PMID] 15781017.
2005
Lipoprotein(a): implications for clinical practice.
Current atherosclerosis reports.
7(5):327-9
[PMID] 16105473.
2005
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
The American journal of cardiology.
96(4):556-63
[PMID] 16098311.
2005
Undertreatment among high-risk dyslipidemic patients: results of a national survey of goal achievement for National Cholesterol Education program Adult Treatment Panel III guidelines
International Journal of Clinical Practice.
59
2004
Aspirin use among heart attack survivors aged 45 and over
.
2004
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview.
Circulation.
110(25):e543-4
[PMID] 15611378.
2004
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group.
Circulation.
110(25):e554-9
[PMID] 15611381.
2004
Effects of a moderate-fat (high-MUFA) and low fat, weight-loss diet on the serum lipid profile in overweight and obese men and women
.
79(2):204-212
2004
Effects of moderate-fat (from monounsaturated fat) and low-fat weight-loss diets on the serum lipid profile in overweight and obese men and women.
The American journal of clinical nutrition.
79(2):204-12
[PMID] 14749224.
2004
Expanding Primary Prevention Efforts: Allowing Consumers Access to Over-The-Counter Statins
American Journal of Cardiology.
94(9A):1F-3F
2004
Explaining disparities in access to high-quality cardiac surgeons.
The Annals of thoracic surgery.
78(1):18-24; discussion 24
[PMID] 15223394.
2004
Guidelines and their Implementation: A Discussion Document Focused on the Best Approaches to Drive Improvement
Vascular Disease Prevention.
1:167-174
2004
International Action on Cardiovascular Disease: A Platform for Success
.
2004
Introduction. Expanding Primary Prevention Efforts: Allowing Consumers Access to Over-the-Counter Statins
American Journal of Cardiology.
94(9A):1F-3F
2004
Lateral automobile impacts and the risk of traumatic brain injury.
Annals of emergency medicine.
44(2):142-52
[PMID] 15278087.
2004
Positioning technology to serve global heart health: the Fifth International Heart Health Conference.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
11(4):265-6
[PMID] 15292758.
2004
Positioning Technology to Serve Global Hearth Health
European Journal of Cardiovascular Prevention & Rehabilitation.
11(4):265-266
2004
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum.
Circulation.
109(25):3112-21
[PMID] 15226228.
2004
The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease.
The American journal of cardiology.
94(9A):4F-8F
[PMID] 15519285.
2003
A dose-ranging study of a new, once-daily, dual-component drug product containing niacin extended-release and lovastatin.
Clinical cardiology.
26(3):112-8
[PMID] 12685616.
2003
American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science.
Circulation.
107(4):645-51
[PMID] 12566381.
2003
Bridging the treatment gap: improving compliance with lipid-modifying agents and therapeutic lifestyle changes.
Preventive cardiology.
6(4):204-11
[PMID] 14605514.
2003
Commentary: Cholesterol Trends Underscore Stalled Progress
.
8(4)
2003
Comparison of the dose-response relationship of two lipid-lowering agents: a Bayesian meta-analysis
.
145:1036-1045
2003
Comparison of the dose-response relationships of 2 lipid-lowering agents: a Bayesian meta-analysis.
American heart journal.
145(6):1036-45
[PMID] 12796760.
2003
Coronary Heart Disease: Mortality, Incidence, and Opening Doors to Therapy
.
20(37)
2003
Drug-induced Metabolic Syndrome: A New Epidemic
.
3(2)
2003
Education and income: double-edged swords in the epidemiologic transition of cardiovascular disease
.
13:S2-S158
2003
Education and income: double-edged swords in the epidemiologic transition of cardiovascular disease.
Ethnicity & disease.
13(2 Suppl 2):S158-63
[PMID] 13677431.
2003
Gestational weight gain and postpartum behaviors associated with weight change from early pregnancy to 1 y postpartum.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
27(1):117-27
[PMID] 12532163.
2003
Guidelines for primary prevention of cardiovascular and cerebrovascular disease for Latin-America and the Caribbean: 2003 update
.
2003
Integration of cases in population-oriented prevention into a problem-based medical curriculum
American Journal of Preventive Medicine.
24(4S):102-107
2003
Integration of the Case-Based Series in Population-Oriented Prevention into a problem-based medical curriculum.
American journal of preventive medicine.
24(4 Suppl):102-7
[PMID] 12744987.
2003
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
Circulation.
107(3):499-511
[PMID] 12551878.
2003
Prevention of Heart Disease-Beyond Hormone Replacement Therapy
.
11(2)
2003
Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial.
Journal of the American College of Cardiology.
42(4):600-10
[PMID] 12932588.
2003
The Role of Inflammatory Markers in CVD: Detection and Treatment
.
2002
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.
Circulation.
106(3):388-91
[PMID] 12119259.
2002
Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians.
Journal of lipid research.
43(2):234-44
[PMID] 11861665.
2002
B vitamins and restenosis after coronary angioplasty.
The New England journal of medicine.
346(14):1093-5
[PMID] 11932482.
2002
Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices.
The American journal of managed care.
8(11):937-46
[PMID] 12437309.
2002
New tools for coronary risk assessment: what are their advantages and limitations?
Circulation.
105(7):886-92
[PMID] 11854132.
2002
Post-MI risk factor management: The scope of the problem
Cardiology in Review.
19(8):3-5
2002
Prevention Conference VI: Diabetes and Cardiovascular disease: Writing Group I: epidemiology.
Circulation.
105(18):e132-7
[PMID] 11994263.
2002
Recommendations for optimal risk management after MI
.
19(8):31-33
2001
AHA scientific statement: summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health. Conference summary from the Nutrition Committee of the American Heart Association.
The Journal of nutrition.
131(4):1322-6
[PMID] 11285345.
2001
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
Journal of the American College of Cardiology.
38(5):1581-3
[PMID] 11691544.
2001
AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
Circulation.
104(13):1577-9
[PMID] 11571256.
2001
Capacity for research in minority health: the need for infrastructure plus will.
The American journal of the medical sciences.
322(5):243-52
[PMID] 11721802.
2001
Design issues in the combination of international data from two rural community cardiovascular intervention programs.
Scandinavian journal of public health. Supplement.
56:33-9
[PMID] 11681561.
2001
Detection and management of hyperlipidemia in the elderly
Cardiology in Review.
18(10):25-32
2001
Different outcomes for different interventions with different focus!–A cross-country comparison of community interventions in rural Swedish and US populations.
Scandinavian journal of public health. Supplement.
56:46-58
[PMID] 11681563.
2001
Dissecting the “black box” of community intervention: background and rationale.
Scandinavian journal of public health. Supplement.
56:5-12
[PMID] 11681564.
2001
Dissecting the “black box” of community intervention: lessons from community-wide cardiovascular disease prevention programs in the US and Sweden.
Scandinavian journal of public health. Supplement.
56:69-78
[PMID] 11681566.
2001
Fluorescence-based, nonradioactive method for efficient detection of the pentanucleotide repeat (TTTTA)(n) polymorphism in the apolipoprotein(a) gene.
Clinical chemistry.
47(10):1758-62
[PMID] 11568083.
2001
Improving your patient’s lipid profile
.
47(5):42-50
2001
Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension.
Circulation.
104(17):2039-44
[PMID] 11673343.
2001
Low-fat and high MUFA diets decrease LDL oxidation in vitro
Journal of Nutrition.
131:1758-1763
2001
Nutritional interventions to reduce cardiovascular disease: individual versus population perspectives.
Current atherosclerosis reports.
3(6):425-7
[PMID] 11602061.
2001
Screening family members at high risk for coronary disease. Why isn’t it done?
American journal of preventive medicine.
20(1):50-5
[PMID] 11137774.
2001
Sex, drugs, and hypertension: a methodological approach for studying a sensitive subject.
International journal of impotence research.
13(1):31-40
[PMID] 11313838.
2001
Summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association.
Circulation.
103(7):1034-9
[PMID] 11181482.
2001
The Norsjö-Cooperstown healthy heart project: a case study combining data from different studies without the use of meta-analysis.
Scandinavian journal of public health. Supplement.
56:40-5
[PMID] 11681562.
2001
The Otsego-Schoharie healthy heart program: prevention of cardiovascular disease in the rural US.
Scandinavian journal of public health. Supplement.
56:21-32
[PMID] 11681560.
2001
Translation of nutritional sciences into medical education: the Nutrition Academic Award Program.
The American journal of clinical nutrition.
74(2):164-70
[PMID] 11470716.
2001
Validation for MEDFICTS, a dietary assessment instrument for evaluating adherence to total and saturated fat recommendations of the National Cholesterol Education Program Step 1 and Step 2 diets.
Journal of the American Dietetic Association.
101(1):81-6
[PMID] 11209589.
2000
Biologic covariation between changes in plasma lipids and Factor VIIc: the greatest factor VIIc decrease is associated with the largest total cholesterol and triglyceride lowering
.
2000
Cholesterol lowering with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms.
Chest.
118(3):756-60
[PMID] 10988199.
2000
Demographics and cardiology, 1950-2050.
Journal of the American College of Cardiology.
35(5 Suppl B):66B-80B
[PMID] 10757372.
2000
Demographics and cardiology, 1950-2050.
Journal of the American College of Cardiology.
35(4):1067-81
[PMID] 10732909.
2000
Diet effects on factor VIIc are mediated by changes in plasma lipids and lipoproteins
.
2000
Divergent approaches to the treatment of dyslipidemia with low levels of high-density lipoprotein cholesterol.
The American journal of cardiology.
86(12A):57L-61L
[PMID] 11374858.
2000
Do antioxidants prevent heart disease?
.
34(12):74-93
2000
Does hypertension and its pharmacotherapy affect the quality of sexual function in women?
American journal of hypertension.
13(6 Pt 1):640-7
[PMID] 10912747.
2000
Guidelines for cardiovascular risk reduction
.
6:31-41
2000
Guidelines for cardiovascular risk reduction
Primary Care.
4:17-29
2000
High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.
Arteriosclerosis, thrombosis, and vascular biology.
20(12):2619-24
[PMID] 11116062.
2000
Long term follow up of patients treated with fenfluramine/phentermine: Low incidence of cardiac outcomes despite increased cardiac valvular abnormalities
.
2000
Lowering dietary saturated fat and total fat reduces the oxidative susceptibility of LDL in healthy men and women.
The Journal of nutrition.
130(9):2228-37
[PMID] 10958817.
2000
Lowering LDL in patients with heart disease: how aggressive should you be?
Cleveland Clinic journal of medicine.
67(7):489-90, 493
[PMID] 10902238.
2000
Nutrient adequacy of diets of adults with hypercholesterolemia after a cholesterol-lowering intervention: long-term assessment.
Journal of the American Dietetic Association.
100(11):1385-8
[PMID] 11103662.
2000
Nutritional interventions in cardiovascular disease: new challenges and opportunities.
Current atherosclerosis reports.
2(6):515-20
[PMID] 11122787.
2000
Over-the-counter statin medications: emerging opportunities for RDs.
Journal of the American Dietetic Association.
100(10)
[PMID] 11183742.
2000
Plasma sphingomyelin level as a risk factor for coronary artery disease.
Arteriosclerosis, thrombosis, and vascular biology.
20(12):2614-8
[PMID] 11116061.
2000
Population benefits of cholesterol reduction: epidemiology, economics, and ethics.
The American journal of cardiology.
85(12A):20E-3E
[PMID] 10858490.
2000
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I.
Circulation.
101(1):E3-E11
[PMID] 10618316.
2000
Race-related differences among patients with left ventricular dysfunction: observations from a biracial angiographic cohort. Harlem-Bassett LP(A) Investigators.
Journal of cardiac failure.
6(3):187-93
[PMID] 10997743.
2000
Raising low levels of high-density lipoprotein cholesterol is an important target of therapy.
The American journal of cardiology.
85(5):645-50, A10
[PMID] 11078282.
2000
Scandinavia’s lessons to the world of public health
Scandinavian Journal of Public Health.
28(3):161-163
2000
The imperative to raise low levels of high-density lipoprotein in cholesterol–a better clinical strategy in the prevention and treatment of coronary artery disease. Introduction.
The American journal of cardiology.
86(12A):1L-4L
[PMID] 11374851.
2000
The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.
Archives of internal medicine.
160(4):459-67
[PMID] 10695686.
2000
The undertreatment of LDL-cholesterol: addressing the challenge.
International journal of cardiology.
74 Suppl 1:S23-8
[PMID] 10856770.
2000
Today’s children, tomorrow’s parents: A global view of the pediatric roots of the cardiovascular disease epidemic
.
3(2):102-105
2000
Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention.
Circulation.
102(25):3137-47
[PMID] 11120707.
2000
Variation of lipids and lipoproteins in premenopausal women compared with men and postmenopausal women. DELTA (Dietary Effects on Lipoproteins and Thrombogenic Activity) Investigators.
Metabolism: clinical and experimental.
49(9):1101-5
[PMID] 11016887.
1999
AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology.
Journal of the American College of Cardiology.
33(6):1751-5
[PMID] 10334455.
1999
Blood pressure control after the onset of coronary artery disease
.
34:2-3
1999
Cardiovascular disease in developing countries: myths, realities, and opportunities.
Cardiovascular drugs and therapy.
13(2):95-104
[PMID] 10372224.
1999
Comparative cholesterolemic response to solid food diets and defined liquid formula diets
.
70:839-846
1999
Comparative lipid and lipoprotein responses to solid-food diets and defined liquid-formula diets.
The American journal of clinical nutrition.
70(5):839-46
[PMID] 10539744.
1999
Epidemiology of HDL cholesterol as a risk factor for coronary heart disease
.
1999
Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement.
Circulation.
99(18):2480-4
[PMID] 10318674.
1999
Guidelines for cardiovascular disease prevention: The approaches in the United States versus Europe
.
9(2):14-17
1999
High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations.
The American journal of clinical nutrition.
70(6):1009-15
[PMID] 10584045.
1999
Matching intensity of intervention with risk for coronary events: Targets for LDL-C, HDL-C, and other risk factors
Preventive Cardiology.
2:11-17
1999
Protein glycosylation mutants of procyclic Trypanosoma brucei: defects in the asparagine-glycosylation pathway.
Glycobiology.
9(2):181-90
[PMID] 9949195.
1999
Shifting the distribution of risk: results of a community intervention in a Swedish programme for the prevention of cardiovascular disease.
Journal of epidemiology and community health.
53(4):243-50
[PMID] 10396552.
1999
Smoking is a geriatric health issue.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
1(4):299-300
[PMID] 11072426.
1999
The rationale for renewed interest by physicians in nutrition.
Current atherosclerosis reports.
1(3):173-5
[PMID] 11122707.
1998
Beyond LDL-cholesterol: can further reductions in CAD risk be achieved by considering triglycerides?
The Canadian journal of cardiology.
14 Suppl B
[PMID] 9627534.
1998
Cardiovascular specialty societies and the emerging global burden of cardiovascular disease: a call to action.
Circulation.
97(6):602-4
[PMID] 9494032.
1998
Commentary: Ecological study of reasons for sharp decline in mortality from ischemic heart disease in Poland since 1991
.
2(3)
1998
Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1.
Arteriosclerosis, thrombosis, and vascular biology.
18(3):441-9
[PMID] 9514413.
1998
Elevated lipoprotein (a) levels in South Asians in North America
.
47(2):182-184
1998
Elevated lipoprotein(a) levels in South Asians in North America.
Metabolism: clinical and experimental.
47(2):182-4
[PMID] 9472967.
1998
Facilitating preventive cardiology practices in primary care: An international perspective
Preventive Cardiology.
1:46-52
1998
Fertility, pregnancy and the management of myeloproliferative disorders.
Bailliere's clinical haematology.
11(4):859-74
[PMID] 10640221.
1998
From science to strategy in heart health
.
1:328-335
1998
Gaps in physician lipid care and outcomes: Physicians continue to face the challenge of improving lipid-lowering strategies to meet national goals for lowered cholesterol
.
61-76
1998
Is sexual dysfunction in hypertensive women uncommon or understudied?
American journal of hypertension.
11(6 Pt 1):733-5
[PMID] 9657635.
1998
LDL-cholesterol: a risk factor for coronary artery disease–from epidemiology to clinical trials.
The Canadian journal of cardiology.
14 Suppl B:3B-10B
[PMID] 9627535.
1998
Lipid lowering in a multidisciplinary clinic compared with primary physician management.
The American journal of cardiology.
81(7):929-33
[PMID] 9555787.
1998
Lipid-lowering therapy in low-risk patients.
JAMA.
279(20):1659-61
[PMID] 9613918.
1998
Longitudinal Changes in Dehydroepiandrosterone Concentrations in Men and Women
Journal of Laboratory and Clinical Medicine.
131(4):316-323
[DOI] 10.1016/S0022-2143(98)90181-0.
1998
Longitudinal changes in dehydroepiandrosterone concentrations in men and women.
The Journal of laboratory and clinical medicine.
131(4):316-23
[PMID] 9579384.
1998
Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study.
Journal of the American College of Cardiology.
31(6):1252-7
[PMID] 9581716.
1998
Physician attitude versus patient outcome: Lipid care for veterans with coronary disease
.
15(7):61-76
1998
Primary and Secondary Prevention of Coronary Artery Disease: Trials of Lipid Lowering With Statins
American Journal of Cardiology.
82(10A, SI):28S-30S
[DOI] 10.1016/S0002-9149(98)90428-3.
1998
Primary and secondary prevention of coronary artery disease: trials of lipid lowering with statins.
The American journal of cardiology.
82(10A):28S-30S
[PMID] 9860353.
1998
Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association.
Circulation.
97(18):1876-87
[PMID] 9603549.
1998
Reduced dietary folate intake is associated with increased levels of oxidized low-density lipoprotein in patients with coronary artery disease
Preventive Cardiology.
2:11-18
1998
Revisited: The nonpharmacologic strategies to treat lipid disorders
.
2(9):33-38
1998
Rural epidemiology: insights from a rural population laboratory.
American journal of epidemiology.
148(10):949-57
[PMID] 9829866.
1998
The American College of Cardiology Evaluation of Preventive Therapeutics (Accept) Study: Attainment of Goals for Comprehensive Risk Reduction in Patients With Coronary Disease in the US
Journal of the American College of Cardiology.
31(2, A)
[DOI] 10.1016/S0735-1097(97)84513-5.
1998
The Singapore Declaration: Forging the will for heart health in the next millennium
.
1(3):182-199
1998
What to consider when conducting a cost-effectiveness analysis in a clinical setting.
Journal of the American Dietetic Association.
98(10):1149-54
[PMID] 9787721.
1998
What’s so passive about passive smoking? Secondhand smoke as a cause of atherosclerotic disease.
JAMA.
279(2):157-8
[PMID] 9440668.
1997
A Symposium: Current Focus in Treating and Managing Coronary Artery Disease and Heart Failure – Introduction
American Journal of Cardiology.
80(8B, SI):H1-H2
[DOI] 10.1016/S0002-9149(97)00812-6.
1997
AHA Science Advisory. Alcohol and heart disease. Nutrition Committee of the American Heart Association.
The American journal of clinical nutrition.
65(5):1567-9
[PMID] 9129493.
1997
Alcohol and heart disease. Nutrition Committee of the American Heart Association
.
65:1567-1569
1997
Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease.
Journal of the American College of Cardiology.
30(2):392-9
[PMID] 9247510.
1997
ApoE genotype does not predict lipid response to changes in dietary saturated fatty acids in a heterogeneous normolipidemic population. The DELTA Research Group. Dietary Effects on Lipoproteins and Thrombogenic Activity.
Arteriosclerosis, thrombosis, and vascular biology.
17(11):2914-23
[PMID] 9409276.
1997
Behavioral issues in the efficacy versus effectiveness of pharmacologic agents in the prevention of cardiovascular disease
Annals of Behavioral Medicine.
19(3):230-238
1997
Behavioral issues in the efficacy versus effectiveness of pharmacologic agents in the prevention of cardiovascular disease.
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
19(3):230-8
[PMID] 9603698.
1997
Can single photon emission computed tomography myocardial perfusion imaging monitor the potential benefit of aggressive treatment of hyperlipidemia?
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
4(6):555-68
[PMID] 9456198.
1997
Cardiovascular disease in African American and white physicians: the Meharry Cohort and Meharry-Hopkins Cohort Studies.
Journal of health care for the poor and underserved.
8(3):270-83; discussion 284
[PMID] 9253218.
1997
Cholesterol and vascular disease in the elderly
Journal of Nutrition Health & Aging.
1:51-61
1997
Cholesterol screening guidelines consensus, evidence, and the departure from common sense.
Circulation.
95(6):1651-3
[PMID] 9118537.
1997
Cholesterol-lowering drugs
Cardiology Clinics.
1:159-180
1997
Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease.
The American journal of cardiology.
80(7):825-30
[PMID] 9381992.
1997
Community based prevention trials: Challenges and directions for public health practice, policy, and research
Annals of Epidemiology.
S7:S113-S120
1997
Current focus in treating and managing coronary artery disease and heart failure
American Journal of Cardiology.
1H-90H
1997
Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease.
The American journal of clinical nutrition.
65(5 Suppl):1674S-1682S
[DOI] 10.1093/ajcn/65.5.1674S.
[PMID] 9129509.
1997
Epidemiology of thrombotic/hemostatic factors and their associations with cardiovascular disease
.
1674S-1682S
1997
Executive summary: community trials for cardiopulmonary health: directions for public health practice, policy, and research
Annals of Epidemiology.
S7:S1-S3
1997
Global perspectives on cardiovascular disease
.
1(1):4-6
1997
Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study.
Archives of internal medicine.
157(13):1436-40
[PMID] 9224221.
1997
Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee.
Circulation.
95(9):2329-31
[PMID] 9142014.
1997
Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women.
Journal of lipid research.
38(3):459-68
[PMID] 9101427.
1997
Strategies to improve risk factor management
.
1997
Symposium summary remarks.
The American journal of cardiology.
80(8B):89H-90H
[PMID] 9373007.
1997
The Treatment Gap in Coronary Artery Disease and Heart Failure: Community Standards and the Post-Discharge Patient
American Journal of Cardiology.
80(8B, SI):H45-H52
[DOI] 10.1016/S0002-9149(97)00820-5.
1997
The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient.
The American journal of cardiology.
80(8B):45H-52H
[PMID] 9372998.
1997
Treatment of hypercholesterolemia in women: equality, effectiveness, and extrapolation of evidence.
JAMA.
277(16):1320-1
[PMID] 9109473.
1997
When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction.
Circulation.
95(6):1683-5
[PMID] 9118557.
1996
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 8. Organization of preventive cardiology service.
Journal of the American College of Cardiology.
27(5):1039-47
[PMID] 8609319.
1996
American College of Physicians guidelines on cholesterol screening.
Annals of internal medicine.
125(12):1008; author reply 1009-10
[PMID] 8967693.
1996
Cardiovascular diseases as a growing health problem in developing countries: the role of nutrition in the epidemiologic transition
.
24:131-146
1996
Cardiovascular diseases as a growing health problem in developing countries: the role of nutrition in the epidemiologic transition.
Public health reviews.
24(2):131-46
[PMID] 8918181.
1996
Cholesterol screening in asymptomatic adults. No cause to change. Task Force on Risk Reduction, American Heart Association
Circulation.
93:1067-1078
1996
Cholesterol update: Who really needs cholesterol-lowering drugs?
.
30:92-108
1996
Coronary heart disease risk factors after total joint arthroplasty of the hip and knee
Journal of Orthopaedic Rheumatology.
9:200-207
1996
Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association.
Circulation.
94(7):1795-800
[PMID] 8840887.
1996
Effects of diets containing high or low amounts of stearic acid on plasma lipoprotein fractions and fecal fatty acid excretion of men.
The American journal of clinical nutrition.
63(3):400-2
[PMID] 8602600.
1996
Executive summary. ACC Bethesda Conference Report, 27th Bethesda Conference
Journal of the American College of Cardiology.
27:961-963
1996
Guidelines for using serum cholesterol, HDL-C, and TG levels as screening tests in adults
.
8:5-6
1996
Lipid lowering: the case for identifying and treating the high-risk patient.
Cardiology clinics.
14(1):117-30
[PMID] 9072285.
1996
Management of cardiovascular risk factors: An integral part of the patient with atherosclerotic disease
.
16-21
1996
Osteoarthritis as a determinant of an adverse coronary heart disease risk profile
.
3:529-533
1996
Osteoarthritis as a determinant of an adverse coronary heart disease risk profile.
Journal of cardiovascular risk.
3(6):529-33
[PMID] 9100089.
1996
Preventing heart attack and death in patients with coronary disease. Endorsed by the board of trustees of the American College of Cardiology.
Cardio-vascular nursing.
32(4):26-8
[PMID] 8846481.
1996
Reliability and changes in validity of self-reported cardiovascular disease risk factors using dual response: the behavioral risk factor survey.
Journal of clinical epidemiology.
49(5):511-7
[PMID] 8636724.
1996
Seasonal variation in parameters related to coronary heart disease risk in young men.
Atherosclerosis.
126(1):117-29
[PMID] 8879440.
1995
Lipid disorders in the elderly should be managed
.
1(6):18-19
1995
Clinical and epidemiologic predictors of recurrent coronary artery disease.
Coronary artery disease.
6(6):447-56
[PMID] 7551265.
1995
Evidence of a healthy estrogen user survivor effect.
Epidemiology (Cambridge, Mass.).
6(3):227-31
[PMID] 7619927.
1995
Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice.
Transplantation proceedings.
27(1):392-4
[PMID] 7879034.
1995
Multinational study results and implications for cardiovascular risk management
.
2(7)
1995
Role of a central laboratory in implementing national cholesterol education panel guidelines in rural practices: model system for managed care.
Clinical chemistry.
41(2):271-4
[PMID] 7874781.
1995
Who will provide preventive services? The changing relationships between medical care systems and public health agencies in health care reform.
Journal of public health management and practice : JPHMP.
1(1):16-27
[PMID] 10186587.
1994
Challenges to implementing the current pediatric cholesterol screening guidelines into practice.
Pediatrics.
94(3):296-302
[PMID] 8065853.
1994
Characteristics of a hypothetical group of hospital controls for a case-control study.
American journal of epidemiology.
139(3):302-11
[PMID] 8116606.
1994
Coffee intake and coronary heart disease.
Annals of epidemiology.
4(6):425-33
[PMID] 7804496.
1994
Effects of a milk chocolate bar per day substituted for a high-carbohydrate snack in young men on an NCEP/AHA Step 1 Diet.
The American journal of clinical nutrition.
60(6 Suppl):1037S-1042S
[DOI] 10.1093/ajcn/60.6.1037S.
[PMID] 7977146.
1994
Effects of a milk chocolate bar per day substituted for a high-carbohydrate snack in young men on an NCEP/AHA step-one diet
.
60:1037S-1042S
1994
How does lipid-lowering therapy rapidly reduce ischemic events?
.
6(10):13-18
1994
Laboratory’s manner of reporting serum cholesterol affects clinical care.
Clinical chemistry.
40(5):847-8
[PMID] 8174267.
1994
Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association Writing Group.
Circulation.
90(6):3125-33
[PMID] 7994868.
1994
Pre-angiography plasma lipoprotein (a) levels in black patients and white patients.
The American journal of medicine.
97(4):404-6
[PMID] 7942952.
1994
Putting medical practice guidelines into practice: the cholesterol model.
American journal of preventive medicine.
10(4):209-16
[PMID] 7803063.
1994
Self-reported physical activity in a rural county: a New York county health census.
American journal of public health.
84(1):29-32
[PMID] 8279607.
1994
Task Force 4: The relationship between cardiovascular specialists and generalists.
Journal of the American College of Cardiology.
24(2):304-12
[PMID] 8034861.
1994
What to advise patients about drinking alcohol. The clinician’s conundrum.
JAMA.
272(12):967-8
[PMID] 7794309.
1993
Atherosclerosis: Quantitative imaging, risk factors, prevalence, and change
Circulation.
87:2-82
1993
Blood cholesterol measurement in young adults.
JAMA.
270(8):936-7; author reply 937
[PMID] 8345640.
1993
Comparison of the effects of diets rich in stearic acid versus myristic acid and lauric acid on platelet fatty acids and excretion of thromboxane A2 and PGI2 metabolites in healthy young men.
Metabolism: clinical and experimental.
42(4):463-9
[PMID] 8487669.
1993
Diagnosis and case finding in familial hypercholesterolemia.
The American journal of cardiology.
72(10):15D-17D
[PMID] 8213491.
1993
Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop.
The American journal of cardiology.
72(10):1D-5D
[PMID] 8105671.
1993
Lipids. Workshop IV. AHA Prevention Conference III. Behavior change and compliance: keys to improving cardiovascular health.
Circulation.
88(3):1397-401
[PMID] 8353907.
1993
Rationale and Design of the Department-Of-Veterans-Affairs High-Density-Lipoprotein Cholesterol Intervention Trial (Hit) for Secondary Prevention of Coronary-Artery Disease in Men With Low High-Density-Lipoprotein Cholesterol and Desirable Low-Density-Lipoprotein Cholesterol
American Journal of Cardiology.
71(1):45-52
[DOI] 10.1016/0002-9149(93)90708-K.
1993
Report of the AHA Prevention Conference III
Circulation.
88:1375-1407
1993
The quest for a cholesterol-decreasing diet: should we subtract, substitute, or supplement?
Annals of internal medicine.
119(7 Pt 1):627-8
[PMID] 8363174.
1993
The rapid reduction in cardiac events with lipid-lowering therapy: mechanisms and implications.
The American journal of cardiology.
72(14):1072-3
[PMID] 8213589.
1993
The role of fatty acid saturation on plasma lipids, lipoproteins, and apolipoproteins: I. Effects of whole food diets high in cocoa butter, olive oil, soybean oil, dairy butter, and milk chocolate on the plasma lipids of young men.
Metabolism: clinical and experimental.
42(1):121-9
[PMID] 8446039.
1993
The role of fatty acid saturation on plasma lipids, lipoproteins, and apolipoproteins: II. The plasma total and low-density lipoprotein cholesterol response of individual fatty acids.
Metabolism: clinical and experimental.
42(1):130-4
[PMID] 8446040.
1993
Validity of cardiovascular disease risk factors assessed by telephone survey: the Behavioral Risk Factor Survey.
Journal of clinical epidemiology.
46(6):561-71
[PMID] 8501483.
1993
Validity of physicians’ self-reports of cardiovascular disease risk factors.
Annals of epidemiology.
3(4):442-7
[PMID] 8275223.
1992
23rd Bethesda conference: access to cardiovascular care. Task Force 1: Scope of the problem.
Journal of the American College of Cardiology.
19(7):1449-60
[PMID] 1593038.
1992
A comparison of the plasma levels of apolipoproteins B and A-1 and other risk factors in men and women with premature coronary atherosclerosis
American Journal of Cardiology.
69:1015-1021
1992
Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop.
Annals of epidemiology.
2(1-2):161-76
[PMID] 1342259.
1992
Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease.
The American journal of cardiology.
69(12):1015-21
[PMID] 1561971.
1992
Coronary intervention trials: Unsolved questions
.
2:9-17
1992
Decaffeinated coffee and serum LDL-cholesterol concentrations.
The American journal of clinical nutrition.
56(3):604-5
[PMID] 1503075.
1992
Evaluation of random digit dialing as a method of control selection in case-control studies.
American journal of epidemiology.
135(2):210-22
[PMID] 1536136.
1992
Long-term predictors of subsequent cardiovascular events with coronary artery disease and ‘desirable’ levels of plasma total cholesterol.
Circulation.
86(4):1165-70
[PMID] 1394924.
1992
Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop.
The American journal of cardiology.
69(17):1458-66
[PMID] 1590237.
1992
The effect of filtered-coffee consumption on plasma lipid levels. Results of a randomized clinical trial.
JAMA.
267(6):811-5
[PMID] 1732652.
1992
Therapeutic management of triglycerides: an international perspective.
The American journal of cardiology.
70(19):26H-31H
[PMID] 1466314.
1991
Alcohol and atherosclerosis.
Annals of internal medicine.
114(11):967-76
[PMID] 2024865.
1991
Guidelines for the detection and treatment of elevated serum cholesterol: which is the baby and which is the bathwater?
Annals of internal medicine.
115(4):324-6
[PMID] 1854119.
1991
Invited commentary: should arteriographic case-control studies be used to identify causes of atherosclerotic coronary artery disease?
American journal of epidemiology.
134(2):123-8
[PMID] 1862796.
1991
Prevention of coronary heart disease in black adults.
Cardiovascular clinics.
21(3):263-76
[PMID] 2044109.
1991
Workshop V–What is a risk factor and what is not–theoretical and practical implications.
The American journal of medicine.
90(2A):50S-52S
[PMID] 1994717.
1990
Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease.
The American journal of cardiology.
65(1):1-5
[PMID] 2294675.
1990
Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography.
Journal of the American College of Cardiology.
16(6):862-70
[PMID] 2146310.
1990
Risk factors for cardiovascular disease in U.S. medical students: the Preventive Cardiology Academic Award Collaborative Data Project.
American journal of preventive medicine.
6(2 Suppl):14-22
[PMID] 2383408.
1990
Screening for hypercholesterolemia.
Annual review of medicine.
41:177-86
[PMID] 2184722.
1990
Strategies for increasing house staff management of cholesterol with inpatients.
American journal of preventive medicine.
6(2 Suppl):51-9
[PMID] 2383413.
1990
The effective treatment of postpericardiotomy syndrome after cardiac operations. A randomized placebo-controlled trial.
The Journal of thoracic and cardiovascular surgery.
100(2):292-6
[PMID] 2200931.
1990
The epidemiology of idiopathic dilated cardiomyopathy in a biracial community.
American journal of epidemiology.
131(1):48-56
[PMID] 2293752.
1990
The prediction of midlife coronary heart disease and hypertension in young adults: the Johns Hopkins multiple risk equations.
American journal of preventive medicine.
6(2 Suppl):23-8
[PMID] 2383409.
1990
Youthful precursors of alcohol abuse in physicians.
The American journal of medicine.
88(4):332-6
[PMID] 2327420.
1989
A clinical look at lipoprotein (a)
.
6(1):15-19
1989
Cardiovascular reactivity to the cold pressor test as a predictor of hypertension.
Hypertension (Dallas, Tex. : 1979).
14(5):524-30
[PMID] 2807514.
1989
Idiopathic dilated cardiomyopathy and atopic disease: epidemiologic evidence for an association with asthma.
American heart journal.
118(4):768-74
[PMID] 2801484.
1989
Influences on CHD incidence and case fatality: medical management of risk factors.
International journal of epidemiology.
18(3 Suppl 1):S217-22
[PMID] 2681021.
1989
LCL subclasses: A critical story unfolds
.
1989
Regional versus general anesthesia in high-risk surgical patients: the need for a clinical trial.
Journal of clinical anesthesia.
1(6):414-21
[PMID] 2624749.
1989
The hybrid hare as a promising model of human atherosclerosis
.
137-140
1989
Trends in CHD in selected countries – overview
International Journal of Epidemiology.
18(3):S99-S100
1988
A practical approach to the patient with a lipid disorder
.
56(11):86-104
1988
Attitudes toward prevention of cardiovascular diseases among first-year students at eight American medical schools, 1983-1985.
Preventive medicine.
17(6):700-11
[PMID] 3244669.
1988
Attitudes Toward Prevention of Cardiovascular-Diseases Among 1St-Year Students at 8 American Medical-Schools, 1983-1985
Preventive Medicine.
17(6):700-711
[DOI] 10.1016/0091-7435(88)90089-8.
1988
Cholesterol management in patients hospitalized for coronary heart disease.
American journal of preventive medicine.
4(3):128-32
[PMID] 3395498.
1988
Community based cardiovascular risk reduction programs
.
37(11):836-839
1988
Community based cardiovascular risk reduction programs.
Maryland medical journal (Baltimore, Md. : 1985).
37(11):836-9
[PMID] 3185155.
1988
Effect of low-dose alcohol use versus abstention on apolipoproteins A-I and B.
The American journal of medicine.
84(5):884-90
[PMID] 3129938.
1988
Hypercholesterolemia in patients undergoing coronary bypass surgery: are they aware, under treatment, and under control?
Heart & lung : the journal of critical care.
17(2):205-8
[PMID] 3127357.
1988
Omega-3 fatty acids: A review of potential benefits and clinical use
.
9(6):558-568
1988
Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients.
The American journal of medicine.
85(5):632-8
[PMID] 3055976.
1988
Risk factors in siblings of people with premature coronary heart disease.
Journal of the American College of Cardiology.
12(5):1273-80
[PMID] 3170971.
1988
The epidemiology of the postpericardiotomy syndrome: a common complication of cardiac surgery.
American heart journal.
116(5 Pt 1):1323-9
[PMID] 3189147.
1987
Atherosclerosis in the hypercholesterolemic hare. Comparison of coronary artery lesions induced by dietary cholesterol in the hare and the rabbit.
Atherosclerosis.
63(2-3):125-35
[PMID] 3827977.
1987
Clinical and angiographic similarities in twins with coronary artery disease.
The American journal of cardiology.
59(4):366-7
[PMID] 3812293.
1987
Clinical and Angiographic Similarities in Twins With Coronary-Artery Disease
American Journal of Cardiology.
59(4):366-367
[DOI] 10.1016/0002-9149(87)90819-8.
1987
Clonal Mapping of the Human Aorta – Relationship of Monoclonal Characteristics, Lesion Thickness, and Age in Normal Intima and Atherosclerotic Lesions
The American Journal Of Pathology.
126(1):33-39
1987
Clonal mapping of the human aorta. Relationship of monoclonal characteristics, lesion thickness, and age in normal intima and atherosclerotic lesions.
The American Journal Of Pathology.
126(1):33-39
1987
Clustering of personality traits in youth and the subsequent development of cancer among physicians.
Journal of behavioral medicine.
10(5):441-7
[PMID] 3430587.
1987
Multiple risk factors for coronary artery disease: behavioral factors in preventive cardiology.
The American journal of cardiology.
60(18):74J-79J
[PMID] 3425558.
1987
Post myocardial infarction cholesterol management by primary physicians
Journal of the American College of Cardiology.
9
1987
Precursors of hypertension in black compared to white medical students.
Journal of chronic diseases.
40(7):721-7
[PMID] 3597674.
1987
Prevalence of hyperlipidemia in heart transplant recipients.
Transplantation.
44(2):323-5
[PMID] 3307054.
1987
Risk factors for progression of coronary heart disease
Coronary Artery Disease.
4(3):47-53
1987
Screening of asymptomatic siblings of patients with premature coronary artery disease.
Circulation.
75(3 Pt 2):II14-7
[PMID] 3815779.
1987
The association of risk factors with arteriographically defined coronary artery disease: what is the appropriate control group?
American journal of epidemiology.
125(5):844-53
[PMID] 3565358.
1987
The effects of age on outcome after coronary bypass surgery.
Circulation.
76(5 Pt 2):V6-12
[PMID] 3499259.
1986
A possible relationship between figure drawing data collected in medical school and later health status among physicians.
Journal of Clinical Psychology.
42(2):363-369
1986
A Possible Relationship Between Figure Drawing Data Collected in Medical-School and Later Health-Status Among Physicians
Journal of Clinical Psychology.
42(2):363-369
[DOI] 10.1002/1097-4679(198603)42:2<363::AID-JCLP2270420226>3.0.CO;2-F.
1986
Coffee consumption and the incidence of coronary heart disease.
The New England journal of medicine.
315(16):977-82
[PMID] 3762618.
1986
Coronary risk factors
.
33-46
1986
Development of Alternate Methods for Scoring the Rorschach Interaction Scale
.
46(4):837-844
1986
Hypercholesterolemia: nutritional and pharmacologic management
.
35(7):549-551
1986
Hypercholesterolemia: nutritional and pharmacologic management.
Maryland medical journal (Baltimore, Md. : 1985).
35(7):549-51
[PMID] 3747746.
1986
Importance of risk factors in the angiographic progression of coronary artery disease.
The American journal of cardiology.
57(1):66-70
[PMID] 3942078.
1986
Long-term effects of cigarette smoking and moderate alcohol consumption on coronary artery diameter. Mechanisms of coronary artery disease independent of atherosclerosis or thrombosis?
The American journal of medicine.
80(1):37-44
[PMID] 3942153.
1986
Major stroke after coronary artery bypass surgery: changing magnitude of the problem.
Journal of vascular surgery.
3(4):684-7
[PMID] 3485725.
1986
Major Stroke After Coronary-Artery Bypass-Surgery – Changing Magnitude of the Problem
Journal of Vascular Surgery.
3(4):684-687
[DOI] 10.1067/mva.1986.avs0030684.
1986
Moderate alcohol consumption and coronary artery disease. A review.
Medicine.
65(4):242-67
[PMID] 3523113.
1986
Physician recognition of CHD risk factors in high-risk patients
.
35(3):214-215
1986
Physician recognition of CHD risk factors in high-risk patients.
Maryland medical journal (Baltimore, Md. : 1985).
35(3):214-5
[PMID] 3702622.
1986
Preventing recurrent myocardial infarction in women with coronary artery disease
.
133-141
1986
Smoking behavior and attitudes toward smoking among hospital nurses.
American journal of public health.
76(12):1449-51
[PMID] 3777295.
1986
The Rorschach Interaction Scale as a potential predictor of cancer.
Psychosomatic Medicine.
48(8):549-563
1985
Stroke following coronary artery bypass grafting: a ten-year study.
The Annals of thoracic surgery.
40(6):574-81
[PMID] 3878134.
1985
Thrombolysis with recombinant tissue plasminogen activator in atherosclerotic thrombotic occlusion.
Journal of the American College of Cardiology.
5(1):85-91
[PMID] 4038373.
1984
Coronary arteriography in the study of the epidemiology of coronary artery disease.
Epidemiologic reviews.
6:140-66
[PMID] 6386500.
1983
Cholesterol-induced atherosclerosis. Clonal characteristics of arterial lesions in the hybrid hare.
Arteriosclerosis (Dallas, Tex.).
3(6):574-80
[PMID] 6651613.
1983
The clonal characteristics of human aortic intima. Comparison with fatty streaks and normal media.
The American Journal Of Pathology.
113(1):33-40
1981
A documented episode of pulmonary vasoconstriction in systemic sclerosis.
Johns Hopkins Medical Journal.
148(2):78-80
1981
Clonal characteristics of cutaneous scars and implications for atherogenesis.
The American Journal Of Pathology.
102(1):49-54
1980
Evidence for two populations of fatty streaks with different roles in the atherogenic process.
Lancet (London, England).
2(8193):496-8
[PMID] 6105558.
1979
Clonal characteristics of experimentally induced “atherosclerotic” lesions in the hybrid hare.
Science (New York, N.Y.).
206(4425):1423-5
[PMID] 505016.
1979
Experience in teaching epidemiology and biostatistics in medical schools
.
23-24
1979
Monoclonal characteristics of organising arterial thrombi: Significance in the origin and growth of human atherosclerotic plaques.
Lancet (London, England).
1(8106):7-11
[PMID] 83516.
1979
The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease.
American journal of epidemiology.
109(3):285-95
[PMID] 222134.
1979
The preventive medicine residency within the School of Public Health: Progress at Johns Hopkins
.
26:12-13
1978
Clonal characteristics in layers of human atherosclerotic plaques. A study of the selection hypothesis of monoclonality.
The American Journal Of Pathology.
93(1):93-102
1978
Clonal Markers in Study of Origin and Growth of Human Atherosclerotic Lesions
.
43(1):10-18
1977
Comparison of gastric contents to pulmonary aspirates for the cytologic diagnosis of Pneuomcystis carinii pneumonia.
Journal of Pediatrics.
90(2):243-244
1977
Corynebacterium sepsis in oncology patients. Predisposing factors, diagnosis, and treatment.
JAMA.
238(16):1737-40
[PMID] 578268.
1977
The human atherosclerotic plaque.
The American Journal Of Pathology.
86(3):657-664
1976
Immunosuppression and plasma exchange in the treatment of Goodpasture’s syndrome
Lancet.
1:711-715
1976
Immunosuppression and plasma-exchange in the treatment of Goodpasture’s syndrome.
Lancet (London, England).
1(7962):711-5
[PMID] 56532.
1975
Clonal characteristics of fibrous plaques and fatty streaks from human aortas.
The American Journal Of Pathology.
81(2):379-387
1975
Effect of ACTH, alpha-MSH, and beta-lipotropin in calcium and phosphorus metabolism in the rabbit
Endocrinology.
97:1593-1596
1975
Use of plasma exchange in treatment of allergic diseases
.
3
1974
Determination of apocerulo-plasma by radioimmunoassay in nutritional copper deficiency, Menkes’ kinky hair syndrome, Wilson’s disease and umbilical cord blood
Pediatric Research.
8:821-824
Grants
Jul 2020
– Mar 2022
Together Transforming and Translating Discovery to Improve Health
Role: Principal Investigator
Funding: NATL INST OF HLTH NCATS
Jul 2020
– Jun 2021
Institutional Career Development Core
Role: Principal Investigator
Funding: NATL INST OF HLTH NCATS
Jul 2019
– Jun 2021
A Randomized Controlled Trial to Test the Effectiveness of Developmental Network Coaching in the Career Advancement of Diverse Early Stage Investigators
Role: Principal Investigator
Funding: MOREHOUSE SCHOOL OF MEDICINE
via NATL INST OF HLTH NIGMS
Jul 2019
– Jun 2020
Together: Transforming and Translating Discovery to Improve Health
Role: Principal Investigator
Funding: NATL INST OF HLTH NCATS
Jul 2019
ACTIVE
OoR Matching Support for CTSI
Role: Project Manager
Funding: UF DIV OF SPONSORED RES MATCHING FUNDS
Aug 2018
– May 2021
Acceptance-Based Therapy Weight Loss Intervention for Adolescents: A Pilot, Randomized Controlled Trial
Role: Other
Funding: NATL INST OF HLTH NHLBI
Apr 2018
– Jul 2019
Together: Transforming and Translating Discovery to Improve Health
Role: Principal Investigator
Funding: NATL INST OF HLTH NCATS
Apr 2018
– Jul 2019
Together: Transforming and Translating Discovery to Improve Health
Role: Principal Investigator
Funding: NATL INST OF HLTH NCATS
Sep 2017
– Dec 2018
Executive Committee Agreement Amendment
Role: Principal Investigator
Funding: BAYER HEALTHCARE
Apr 2017
– Mar 2018
Together: Transforming and Translating Discovery to Improve Health
Role: Faculty
Funding: NATL INST OF HLTH NCATS
Apr 2017
– Mar 2018
Together: Transforming and Translating Discovery to Improve Health
Role: Principal Investigator
Funding: NATL INST OF HLTH NCATS
Jan 2017
– Jun 2021
mTOR pathway in breast cancer subtypes by race: A molecular pathological study
Role: Other
Funding: NATL INST OF HLTH NCI
Apr 2016
– Mar 2017
TOGETHER: TRANSFORMING AND TRANSLATING DISCOVERY TO IMPROVE ,HEALTH ,
Role: Principal Investigator
Funding: NATL INST OF HLTH NCATS
Nov 2015
– Apr 2020
An Ethnicity-Specific MetS Severity Score to Assess Risk: The Jackson Heart
Role: Project Manager
Funding: NATL INST OF HLTH NHLBI
Oct 2015
– Mar 2019
OneFlorida Clinical Research Consortium Phase II
Role: Project Manager
Funding: PATIENT-CENTERED OUTCOMES RES INST
May 2015
– Mar 2016
Together: Transforming and Translating Discovery to
Role: Principal Investigator
Funding: NATL INST OF HLTH NCATS
Apr 2015
– Jun 2021
Clinical and Translational Science Institute (CTSI)
Role: Project Manager
Funding: UF DIV OF SPONSORED RES MATCHING FUNDS
Education
PhD
1983
·
The Johns Hopkins University, School of Hygiene and Public Health
M.D.
1976
·
The Johns Hopkins University, School of Medicine
MPH
1976
·
The Johns Hopkins University, School of Hygiene and Public Health
B.A.
1973
·
The Johns Hopkins University
Contact Details
Phones:
- Business:
- (352) 273-5048
Emails:
- Business:
- tapearson@ufl.edu
Academic Program Spec II:
Addresses:
- Business Mailing:
-
PO Box 100231
GAINESVILLE FL 32610 - Business Street:
-
2004 MOWRY RD
GAINESVILLE FL 32610